Microsofts New Trusted Tech Lead Navigates the Tension Between AI Speed and Responsibility Fed Rate Hike Expectations Resurface as Inflation Surge Fuels Market Pricing China Industrial Profits Surge 247 in April Fastest Gain in Over Two Years India Emerges as Key Driver of AI Demographic Shifts and Energy Security in APAC Colliers Report GIFT City Emerges as Potential Portal for Global Equity Access 110th Indianapolis 500 Viewing Guide and Potential Economic Impact CLNN Q1 2026 Earnings Significant EPS Beat Despite PreRevenue Status and Stock Decline Lincoln National Corporation LNC Q1 2026 Earnings BottomLine Beat Amidst Strategic Discipline LNC Q1 2026 Earnings EPS Surpasses Estimates Despite Absent Revenue Disclosure XOMAP Q1 2026 Earnings EPS Misses Estimates with Significant Negative Surprise NWSA Q1 2026 Earnings EPS Beat by 1206 on Strong Operating Performance Jiayin Group Q4 2024 Earnings EPS Delivers Solid Profitability Stock Gains Over 6 Fortive FTV Shows Modest Decline Amid Consolidation Range Axiom Intelligence Acquisition Corp 1 Units AXINU Gains 436 as SPAC Momentum Builds Ball Corporation BALL Edges Higher as Packaging Sector Shows Stability Circle Internet Group CRCL Finds Demand at Support Closing Near Session Highs Azenta Inc AZTA Rallies 159 as Stock Tests Key Technical Levels Enhanced Games Backed by Donald Trump Jr and Peter Thiel Steroid Olympics Set for Sunday Debut FNWD Q1 2026 Earnings EPS Miss Slightly as Stock Nudges Higher Ross Stores ROST Surges Over 8 Retail Resilience in Focus VTEX Q1 2026 Earnings EPS Misses Estimates as Stock Declines Marker Therapeutics Inc MRKR Q1 2026 Earnings EPS Beat Expectations Amid Development Stage Operations AEP Q1 2026 Earnings EPS Beat Surprises Shares Edge Higher XPO Q1 2026 Earnings EPS Beats Estimates by 14 but Stock Falls on Revenue Concerns RTX Q1 2026 Earnings EPS Surges Past Estimates with 161 Surprise RB Global Inc RBA Q1 2026 Earnings EPS Slightly Beats Estimates Stock Rises on Positive Momentum Autolus Therapeutics Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline